Applications / Payers

Make the evidence for reimbursement clear.

Help payers judge affordability, value for money, and reimbursement design from the same evidence base.

Support decisions on whether and under which conditions an innovation should be reimbursed.

Show value for money with transparent assumptions and scenario comparison.

Assess where the innovation creates the most value and which groups should be prioritised.

Support practical discussion on affordability, commissioning, and contracting.

Reimbursement context

Reimbursement has to balance affordability and value.

Payers need transparent assumptions on eligible populations, uptake, cost-effectiveness, and budget impact.

Payers need to understand whether the innovation delivers enough value for money within real budget constraints.

Reimbursement often depends on which patients benefit most, how the technology is used, and what safeguards are needed.

The question is rarely whether uncertainty exists, but whether it is visible enough to support a responsible reimbursement decision.

What to assess

Explore how eligible patient groups and conditions of use affect costs and health outcomes.

Show the short- and medium-term financial consequences of adoption across relevant populations and settings.

Assess how costs, outcomes, and pathway effects combine into a clearer value case.

Support decisions on eligibility, conditions of use, commissioning, and contracting structure.

How Medip helps

Compare uptake scenarios and see which assumptions have the largest effect on results.

Model how value changes across target groups, uptake assumptions, and conditions for use.

Show where the evidence is strong, where assumptions matter most, and what remains less certain.

Give payers and providers a shared view of expected costs, outcomes, and uncertainty.

Join the discussion

Explore the populations, comparators, and outcomes relevant to your reimbursement discussion.